
Trump’s order to quicken US drug-making plant approvals will not impact Indian pharma industry: Uday Bhaskar
The order, issued on Monday, also directed the US Food and Drug Administration (USFDA) to streamline reviews and work with domestic manufacturers to provide early support before facilities come online The executive order to reduce the timeline for approval …